ABSTRACT
AIMS: To validate a previously developed set of explicit criteria for the appropriateness of hospital admission among these patients using the RAND/UCLA Appropriateness Methodology (RAM). METHODS: We conducted a prospective cohort study of patients experiencing symptoms of COPD exacerbation seen in the emergency departments (ED) of 16 hospitals belonging to the Spanish National Health Service. Sociodemographic and clinical variables needed to assess appropriateness were recorded. Main outcomes were mortality, severe COPD evolution, complications at follow up, and three patient-reported measures: dyspnoea level, capacity for physical activity and perceived health status. RESULTS: Appropriately admitted patients were more likely to die (6.70% vs. 2.68%, p = 0.0102) than inappropriately admitted patients, and were more likely to develop severe evolution (27.09% vs. 6.08%, p < 0.0001) and complications (18.72% vs. 11.92%, p = 0.0244). Among discharged patients, no significant differences were observed in clinical outcomes. All patients exhibited worse dyspnoea and capacity for physical activity after exacerbation, but changes among appropriately admitted patients were less than among appropriately discharged patients. CONCLUSION: Our appropriateness criteria identified patients in worse condition at ED arrival who were more likely to benefit from admission in terms of mortality and COPD evolution.
Subject(s)
Health Status , Hospitalization , Pulmonary Disease, Chronic Obstructive/therapy , Aged , Aged, 80 and over , Cohort Studies , Female , Humans , Male , Prospective Studies , Pulmonary Disease, Chronic Obstructive/complications , Pulmonary Disease, Chronic Obstructive/mortalityABSTRACT
No disponible
Subject(s)
Humans , Cystic Fibrosis/microbiology , Stenotrophomonas maltophilia/pathogenicity , Communicable Diseases, Emerging , Stenotrophomonas maltophilia/isolation & purification , Gram-Negative Bacterial Infections , Drug Resistance, Multiple , Anti-Bacterial Agents/therapeutic useABSTRACT
Bronchial benign tumors comprise fewer than 4% of pulmonary neoplasms. Endobronchial lipoma is an extremely rare benign neoplasm accounting for only 0.1% to 0.5% of all lung tumors. Clinical symptoms of lipoma depend on the location of the tumor, the severity of bronchial obstruction, and the functional and anatomical effects on the parenchyma distal to the obstruction. Computed axial tomography usually reveals the adipose composition of the lipomatous tumor. We report the case of an 83-year-old man diagnosed with community-acquired pneumonia that led to complications: pleural empyema caused by Haemophilus influenzae infection and atelectasis of the right middle and lower lobes secondary to a lipomatous endobronchial obstruction. Removal of the bronchial lipoma was performed by laser resection.
Subject(s)
Bronchial Neoplasms/complications , Empyema, Pleural/etiology , Lipoma/complications , Aged , Aged, 80 and over , Bronchial Neoplasms/diagnosis , Bronchial Neoplasms/diagnostic imaging , Bronchial Neoplasms/surgery , Bronchoscopy , Community-Acquired Infections/complications , Empyema, Pleural/complications , Empyema, Pleural/diagnostic imaging , Haemophilus Infections/complications , Haemophilus influenzae , Humans , Laser Therapy , Lipoma/diagnosis , Lipoma/diagnostic imaging , Lipoma/surgery , Male , Pneumonia/complications , Pulmonary Atelectasis/etiology , Radiography, Thoracic , Tomography, X-Ray ComputedABSTRACT
No disponible
Subject(s)
Middle Aged , Adult , Male , Female , Humans , Carcinoma, Large Cell , Carbon Monoxide Poisoning , Pancreatic Neoplasms , Lung Diseases , Lung NeoplasmsABSTRACT
El uso del nuevo anticolinérgico tiotropio (Spiriva,Ba679 BR) puede suponer un avance en la terapia broncodilatadora de la enfermedad pulmonar obstructiva crónica (EPOC), lo que viene determinado por su especificidad de acción sobre los diferentes subtipos de receptores muscarínicos. Ello le confiere un efecto prolongado, y se puede utilizar una vez al día, lo que facilitará la adhesión y cumplimentación del plan terapéutico por parte del paciente. El tiotropio presenta una mayor potencia de acción que su predecesor, el bromuro de ipratropio (AU)
Subject(s)
Humans , Cholinergic Antagonists/therapeutic use , Bronchodilator Agents/therapeutic use , Lung Diseases, Obstructive/drug therapy , Cholinergic Antagonists/chemistry , Reaction Time , Dose-Response Relationship, Drug , Drug EvaluationABSTRACT
No disponible
Subject(s)
Aged , Aged, 80 and over , Male , Humans , Lymphoma, B-Cell , Methylprednisolone , Glucocorticoids , Lung NeoplasmsABSTRACT
No disponible
Subject(s)
Adolescent , Adult , Humans , Sweat , Cystic Fibrosis Transmembrane Conductance Regulator , Mutation , Biological Transport, Active , Cystic Fibrosis , GenotypeABSTRACT
OBJECTIVE: The walking test is a useful and objective method for evaluating the tolerance for exercise in patients with chronic bronchopulmonary diseases. Our objective was to check the reproducibility of this test and evaluate whether there are differences between tests of varying duration (2 and 6 minutes) in a group of patients with cystic fibrosis. PATIENTS AND METHODS: We utilized the walking test on 29 patients who were in a stable phase and under care in the Cystic Fibrosis Unit of our hospital. Two tests were carried out, one of 2 minutes and the other of 6 minutes duration, both of which were repeated after a 15-minute interval. RESULTS: The reproducibility of the walking test in this type of patient was very good and we found an excellent correlation between the two-minute test and the six-minute test. We did not observe a training effect when the test was repeated. CONCLUSIONS: The two minute walking test has a high reproducibility and we propose this test, because it is shorter and more comfortable for pediatric patients with cystic fibrosis, in order to evaluate the evolution, progressive deterioration of the of the patient and the response to different types of treatments.
Subject(s)
Cystic Fibrosis , Walking/physiology , Adolescent , Adult , Child , Chronic Disease , Exercise Test/methods , Exercise Tolerance/physiology , Female , Humans , Male , Predictive Value of Tests , Reproducibility of ResultsABSTRACT
We present a 69 years old male patient diagnosed of rheumatoid arthritis (RA) with signs of pleuropulmonar disease. The diagnose of RA was done of 49 years and since then treated with non steroid antiinflammatory drugs and during the acute phases of RA with steroid drugs. The pleural effusions showed an exudate with pseudochilothorax criteria with acid pH acid low glucose concentrations. The cytological study of the effusion demonstrated the presence of characteristic mononuclear cells.
